Intein-Fused DNA Polymerase for Hot-Start Amplification Specificity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current DNA polymerases used in PCR and isothermal amplification suffer from nonspecific product formation, leading to low yield and ambiguous results, particularly in clinical applications, and existing hot start technologies are limited by incomplete inhibition, high cost, and slow production scaling.
Innovation Solution
Fusion proteins are developed by inserting an intein at a designated position within the DNA polymerase, inhibiting its activity until activated by regulated splicing, allowing for conditionally controlled DNA polymerase activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If DNA polymerase is used at room temperature, then DNA synthesis can proceed, but nonspecific products are formed leading to low yield and ambiguous results
Solution Approach 1:
The intein is inserted into the DNA polymerase to create an auto-inhibited state at room temperature, preventing nonspecific activity before the reaction is initiated. This preliminary inhibition ensures that the polymerase only becomes active when specifically triggered by heat-induced splicing, thereby eliminating nonspecific products while preserving the ability to produce high yields of target DNA when properly activated
2Reliability
If hot start technologies are used to inhibit DNA polymerase, then specificity is improved, but production scaling is slow and cost increases
Solution Approach 1:
The DNA polymerase is engineered with an auto-inhibition mechanism where the intein automatically regulates its own activity through temperature-dependent splicing. This self-regulating system eliminates the need for external blocking reagents or complex hot start formulations, enabling straightforward manufacturing and rapid scaling while maintaining high specificity. The polymerase serves its own inhibition and activation needs without requiring additional manufactured components
3Productivity
If more samples are processed together, then productivity increases, but nonspecific product accumulation occurs due to preparation time
Solution Approach 1:
All samples are prepared with the auto-inhibited DNA polymerase in advance at room temperature, where the intein prevents any nonspecific activity during sample preparation and batching. When all samples are ready, a single heat treatment simultaneously activates all polymerases through splicing, allowing multiple samples to be processed together without nonspecific product accumulation, thereby maintaining high specificity while increasing overall productivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The fusion proteins provide high specificity and yield in DNA synthesis, overcoming the limitations of existing technologies by enabling controlled and efficient DNA amplification methods.
Implementation Method 1
the splicing activity of the intein is regulated by one or more factors. Modification of the one or more factors thereby induces activation of protein splicing, resulting in release of the target DNA polymerase from the fusion protein
Data Source
AI summary
The present invention relates to fusion proteins and methods of using the same. Specifically, invention relates to fusion proteins comprising an intein and a DNA polymerase, and methods of using the same for DNA synthesis.